{
    "1651467992159465472": {
        "attachments": {
            "media_keys": [
                "3_1651467979761020928"
            ]
        },
        "author_id": "5383942",
        "created_at": "2023-04-27T06:07:06.000Z",
        "edit_history_tweet_ids": [
            "1651467992159465472"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 60,
                    "normalized_text": "RSV",
                    "probability": 0.5226,
                    "start": 58,
                    "type": "Other"
                },
                {
                    "end": 143,
                    "normalized_text": "European Medicines Agency",
                    "probability": 0.5328,
                    "start": 119,
                    "type": "Other"
                },
                {
                    "end": 204,
                    "normalized_text": "CHMP",
                    "probability": 0.4292,
                    "start": 201,
                    "type": "Organization"
                }
            ],
            "urls": [
                {
                    "display_url": "gsk.com/en-gb/media/pr\u2026",
                    "end": 249,
                    "expanded_url": "https://www.gsk.com/en-gb/media/press-releases/",
                    "start": 226,
                    "status": 200,
                    "unwound_url": "https://www.gsk.com/en-gb/media/press-releases/",
                    "url": "https://t.co/9iDhexqgXa"
                },
                {
                    "display_url": "pic.twitter.com/9d0aoWnJDS",
                    "end": 273,
                    "expanded_url": "https://twitter.com/GSK/status/1651467992159465472/photo/1",
                    "media_key": "3_1651467979761020928",
                    "start": 250,
                    "url": "https://t.co/9d0aoWnJDS"
                }
            ]
        },
        "id": "1651467992159465472",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 4688,
            "like_count": 16,
            "quote_count": 1,
            "reply_count": 0,
            "retweet_count": 7
        },
        "text": "News for investors and media: Today we announced that our RSV vaccine candidate has gained a positive opinion from the European Medicines Agency\u2019s (EMA) Committee for Medicinal Products for Human Use\u202f(CHMP).  \n\nFind out more: https://t.co/9iDhexqgXa https://t.co/9d0aoWnJDS"
    }
}